NIH pauses stem cell trial after Brigham calls to retract 'fabricated' foundational research

NIH's National Heart, Lung, and Blood Institute (NHLBI) said Monday it will pause the Phase II CONCERT-HF trial testing a cardiac stem cell therapy as recent calls for retraction of journal articles in related research fields have "raised concerns about the scientific

Read the full 420 word article

User Sign In